Internal Medicine, Endocrinology, Diabetes, & Metabolism · Beaumont, TX
NPI
1487667127
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3030 North St, Suite,560
Beaumont, TX, 77702
Phone (409) 835-9834
Groups this clinician bills Medicare through
Medicare paid, 2024
$872K
49,937 services
Medicare patients, 2024
1,160
Average age 74
Drug cost, 2024
$2.0M
6,208 prescriptions
Company payments, 2025
$2,653
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose M Ortiz was code J0897 (injection, denosumab, 1 mg), 17,640 times for 169 patients. In total Jose M Ortiz billed 49,937 services in 47 codes, and Medicare paid $872K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 17,640 | 169 | $20.49 | $361K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 13,020 | 11 | $8.54 | $111K |
| J1306 Injection, inclisiran, 1 mg | Office | 4,544 | 12 | $9.56 | $43K |
| 99214 Office E&M - Established | Office | 1,451 | 789 | $80.24 | $116K |
| 36415 Venipuncture Blood Collection | Office | 1,433 | 615 | $8.63 | $12K |
| 83036 Blood Count | Office | 980 | 384 | $9.51 | $9,321 |
| 84520 Clinical Chemistry | Office | 922 | 465 | $3.87 | $3,565 |
| 82565 Clinical Chemistry | Office | 809 | 449 | $5.02 | $4,061 |
| 82310 Clinical Chemistry | Office | 796 | 441 | $5.06 | $4,028 |
| 84132 Clinical Chemistry | Office | 788 | 418 | $4.65 | $3,664 |
| 80076 Clinical Chemistry | Office | 725 | 374 | $7.99 | $5,794 |
| 80061 Clinical Chemistry | Office | 718 | 362 | $13.08 | $9,394 |
| 82947 Clinical Chemistry | Office | 677 | 332 | $3.85 | $2,606 |
| 84443 Clinical Chemistry | Office | 646 | 442 | $16.44 | $11K |
| 99213 Office E&M - Established | Office | 509 | 372 | $57.00 | $29K |
By year: 2022 $730K for 38,616 services; 2023 $743K for 39,979 services; 2024 $872K for 49,937 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,433 | 615 | $8.63 | $12K |
| 83036 Blood Count | 980 | 384 | $9.51 | $9,321 |
| 84520 Clinical Chemistry | 922 | 465 | $3.87 | $3,565 |
| 82565 Clinical Chemistry | 809 | 449 | $5.02 | $4,061 |
| 82310 Clinical Chemistry | 796 | 441 | $5.06 | $4,028 |
| 84132 Clinical Chemistry | 788 | 418 | $4.65 | $3,664 |
| 80076 Clinical Chemistry | 725 | 374 | $7.99 | $5,794 |
| 80061 Clinical Chemistry | 718 | 362 | $13.08 | $9,394 |
| 82947 Clinical Chemistry | 677 | 332 | $3.85 | $2,606 |
| 84443 Clinical Chemistry | 646 | 442 | $16.44 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Jose M Ortiz prescribed most often to Medicare patients was Atorvastatin Calcium, with 431 prescriptions and refills. In total Jose M Ortiz wrote 6,208 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 431 | 1,199 | 152 | $4,775 |
| Synthroid Levothyroxine Sodium | 414 | 930 | 127 | $34K |
| Levothyroxine Sodium Generic | 366 | 935 | 127 | $4,573 |
| Ozempic Semaglutide | 355 | 565 | 92 | $524K |
| Rosuvastatin Calcium Generic | 269 | 689 | 102 | $3,353 |
| Metformin Hcl Generic | 232 | 623 | 80 | $2,703 |
| Pioglitazone Hcl Generic | 207 | 523 | 66 | $2,931 |
| Metformin Hcl Er Metformin Hcl | 205 | 501 | 69 | $1,682 |
| Hydrochlorothiazide Generic | 162 | 388 | 46 | $724 |
| Mounjaro Tirzepatide | 146 | 225 | 41 | $234K |
| Repaglinide Generic | 143 | 329 | 46 | $5,337 |
| Jardiance Empagliflozin | 122 | 246 | 38 | $138K |
| Ezetimibe Generic | 120 | 281 | 38 | $3,375 |
| Amlodipine Besylate Generic | 119 | 335 | 39 | $782 |
| Alendronate Sodium Generic | 119 | 260 | 33 | $718 |
Brand drugs: 2,257 claims; generic drugs: 3,716 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose M Ortiz $2,653 ($2,653 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $316 |
| Novo Nordisk Inc NVO | 13 | $290 |
| Medtronic, Inc. MDT | 8 | $234 |
| Dexcom, Inc. DXCM | 20 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $168 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $158 |
| Madrigal Pharmaceuticals MDGL | 4 | $127 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $107 |
| Lilly USA, LLC LLY | 6 | $101 |
| Corcept Therapeutics CORT | 5 | $98.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.